FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988001682> ?p ?o ?g. }

• W1988001682 endingPage "135" @default.
• W1988001682 startingPage "125" @default.
• W1988001682 abstract "The nasal cavity possesses many advantages as a site for drug delivery, such as; ease of administration, applicability for long-term treatments and a large surface area for absorption. One important limiting factor for nasal drug delivery is the limited time available for absorption within the nasal cavity due to mucociliary clearance. Several drug delivery systems including different kinds of microspheres have been tried for encapsulation of drugs and increasing the residence time in nasal cavity. In this study the clearance rate of three kinds of microspheres (Alginate, PLGA, and Sephadex) was determined by gamma-scintigraphy with lactose powder being used as negative control. 99mTc labeled microspheres were prepared using technetium pertechnetate in the presence of a potent reducing agent, stannus chloride. The labeling procedure was set in a manner that each 3–5 mg of microspheres contained 2 MBq of radioactivity. Labeling efficiency was calculated by paper chromatography using acetone as a mobile phase. Each delivery system containing 2 MBq of activity was administered into right nostril of four healthy volunteers and 1 min static views were repeated each half an hour until 4 h. Clearance rates were compared using two regions of interest (ROIs); the initial site of deposition of particles, and all of the nasopharynx region. The clearance rate of each one of microspheres was calculated after applying the physical decay corrections. The mean labeling efficiencies for Alginate, PLGA, and Sephadex microspheres were calculated as 60%, 59%, and 74%, respectively. The cleared percent of formulations from nasopharynx region after 4 h was determined as follows: PLGA microspheres 48.5 ± 8.2%; Alginate microspheres 45.0 ± 0.8%; Sephadex microspheres 63.1 ± 3.4%; lactose powder 74.5 ± 4.9%. Alginate and PLGA microspheres showed the lowest clearance rate compared to lactose powder (P < 0.0001 and P < 0.001, respectively), followed by Sephadex microspheres (P < 0.01). The clearance profiles of formulations from deposition ROI and nasopharynx ROI were identical. This study shows that Alginate and PLGA microspheres have the highest mucoadhesion properties and are suitable nasal delivery systems. Futhermore, this study proves that limiting step for the nasal clearance of nasally administered particulate systems is their dislocation from the initial site of deposition, and their following interactions with mucus layer in the rest of the nasal passage does not significantly affect the clearance time." @default.
• W1988001682 created "2016-06-24" @default.
• W1988001682 creator A5003971714 @default.
• W1988001682 creator A5029460290 @default.
• W1988001682 creator A5039680633 @default.
• W1988001682 creator A5066424438 @default.
• W1988001682 creator A5071043316 @default.
• W1988001682 date "2004-08-01" @default.
• W1988001682 modified "2023-10-12" @default.
• W1988001682 title "Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy" @default.
• W1988001682 cites W1489129182 @default.
• W1988001682 cites W1971527092 @default.
• W1988001682 cites W1973818971 @default.
• W1988001682 cites W1974558951 @default.
• W1988001682 cites W1976182725 @default.
• W1988001682 cites W1976677427 @default.
• W1988001682 cites W1981095257 @default.
• W1988001682 cites W1987336645 @default.
• W1988001682 cites W1987881692 @default.
• W1988001682 cites W1991708468 @default.
• W1988001682 cites W1992497253 @default.
• W1988001682 cites W1994213150 @default.
• W1988001682 cites W1997899946 @default.
• W1988001682 cites W1999244556 @default.
• W1988001682 cites W2001008105 @default.
• W1988001682 cites W2009120153 @default.
• W1988001682 cites W2009169930 @default.
• W1988001682 cites W2009426961 @default.
• W1988001682 cites W2011367067 @default.
• W1988001682 cites W2022500225 @default.
• W1988001682 cites W2024941625 @default.
• W1988001682 cites W2028311524 @default.
• W1988001682 cites W2030151349 @default.
• W1988001682 cites W2037002669 @default.
• W1988001682 cites W2038602532 @default.
• W1988001682 cites W2042896447 @default.
• W1988001682 cites W2047169908 @default.
• W1988001682 cites W2047529955 @default.
• W1988001682 cites W2058339985 @default.
• W1988001682 cites W2063915040 @default.
• W1988001682 cites W2066133524 @default.
• W1988001682 cites W2067800692 @default.
• W1988001682 cites W2069917285 @default.
• W1988001682 cites W2074472941 @default.
• W1988001682 cites W2085264307 @default.
• W1988001682 cites W2086918985 @default.
• W1988001682 cites W2090063729 @default.
• W1988001682 cites W2091812272 @default.
• W1988001682 cites W2092723839 @default.
• W1988001682 cites W2094299539 @default.
• W1988001682 cites W2101975583 @default.
• W1988001682 cites W2116215627 @default.
• W1988001682 cites W2156178115 @default.
• W1988001682 cites W25951409 @default.
• W1988001682 cites W4211124701 @default.
• W1988001682 cites W4362066032 @default.
• W1988001682 doi "https://doi.org/10.1016/j.ijpharm.2004.05.009" @default.
• W1988001682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15265553" @default.
• W1988001682 hasPublicationYear "2004" @default.
• W1988001682 type Work @default.
• W1988001682 sameAs 1988001682 @default.
• W1988001682 citedByCount "75" @default.
• W1988001682 countsByYear W19880016822012 @default.
• W1988001682 countsByYear W19880016822013 @default.
• W1988001682 countsByYear W19880016822014 @default.
• W1988001682 countsByYear W19880016822015 @default.
• W1988001682 countsByYear W19880016822016 @default.
• W1988001682 countsByYear W19880016822017 @default.
• W1988001682 countsByYear W19880016822018 @default.
• W1988001682 countsByYear W19880016822019 @default.
• W1988001682 countsByYear W19880016822020 @default.
• W1988001682 countsByYear W19880016822021 @default.
• W1988001682 countsByYear W19880016822022 @default.
• W1988001682 countsByYear W19880016822023 @default.
• W1988001682 crossrefType "journal-article" @default.
• W1988001682 hasAuthorship W1988001682A5003971714 @default.
• W1988001682 hasAuthorship W1988001682A5029460290 @default.
• W1988001682 hasAuthorship W1988001682A5039680633 @default.
• W1988001682 hasAuthorship W1988001682A5066424438 @default.
• W1988001682 hasAuthorship W1988001682A5071043316 @default.
• W1988001682 hasConcept C114682108 @default.
• W1988001682 hasConcept C126322002 @default.
• W1988001682 hasConcept C127413603 @default.
• W1988001682 hasConcept C136229726 @default.
• W1988001682 hasConcept C141071460 @default.
• W1988001682 hasConcept C163994747 @default.
• W1988001682 hasConcept C177322064 @default.
• W1988001682 hasConcept C178790620 @default.
• W1988001682 hasConcept C181199279 @default.
• W1988001682 hasConcept C185592680 @default.
• W1988001682 hasConcept C189942447 @default.
• W1988001682 hasConcept C202751555 @default.
• W1988001682 hasConcept C2777714996 @default.
• W1988001682 hasConcept C2778801703 @default.
• W1988001682 hasConcept C2779820397 @default.
• W1988001682 hasConcept C2780165375 @default.
• W1988001682 hasConcept C42360764 @default.
• W1988001682 hasConcept C43617362 @default.

• next